Bayer Aktiengesellschaft

Wolfgang Krohn

Karl G Metzger

Michael Preiss

Michael Walkowiak

Frank Richter

Werner Mormann

Ernst Meisert

Klaus Brecht

Jurgen Weisser

Franz-Josef Bohne

Carl-Gerd Dieris

Eric Bischof

Andreas Flink

Gerhard Henes

Attila Molnar

J Urgen Dahmer

Novel microcapsules are characterized in that the walls thereof consist of reaction products of crosslinking agents with iminooxadiazinedione isocyanates or the walls thereof contain such reaction products. A process for the production of such microcapsules has also been found, as have carbonless copying papers containing such microcapsules.

Microcapsules using iminooxadiazinedione polyisocyanates

Triisocyanates are produced by gas phase phosgenation of the corresponding (cyclo)aliphatic triamines having three primary amine groups.

Process for preparing triisocyanates

The instant invention is directed to a process for the production of a cellular polyurethane elastomer having a density of 0.45 to 0.8 g/cm.sup.3, comprising:

Process for the production of cellular polyurethane elastomers

Penicillin and cephalosporin derivatives characterized by the presence of a nitroalkyl, nitrocycloalkyl, nitrophenylalkyl or nitroanilinoalkyl group in the side chain are antibacterial agents. The compounds, of which 6-(2-nitro-3,3-dimethylbutyrylamido)-penicillanic acid, 7-nitroacetamido-3-methyl-ceph-3-em-4-carboxylic acid, and 6-[D-.alpha.-(2-nitro-2-methylpropionylamido)phenylacetamido]-penicillanic acid are typical embodiments, are prepared by reacting 6-amino-penicillanic acid, 7-amino-cephalosporanic acid (or derivative thereof) or an .alpha.-substituted-.alpha.-amino-acetamido-penicillanic acid with an appropriate nitrated carboxylic acid or an equivalent nitrated acylating agent.

Cephalosporin derivatives

Penicillin and cephalosporin derivatives characterized by the presence of a nitroalkyl, nitrocycloalkyl, nitrophenylalkyl or nitroanilinoalkyl group in the side chain are antibacterial agents. The compounds, of which 6-(2-nitro-3,3-dimethylbutyrylamido)-penicillanic acid, 7-nitroacetamido-3-methyl-ceph-3-em-4-carboxylic acid, and 6-[D-.alpha.-(2-nitro-2-methylpropionylamido)phenylacetamido] pencillanic acid are typical embodiments, are prepared by reacting 6-amino-penicillanic acid, 7-amino-cephalosporanic acid (or derivative thereof) or an .alpha.-substituted-.alpha.-amino-acetamido-penicillanic acid with an appropriate nitrated carboxylic acid or an equivalent nitrated acylating agent.

Nitro-.beta.-lactam antibiotics and processes for their preparation and

Penicillin and cephalosporin derivatives characterized by the presence of a nitroalkyl, nitrocycloalkyl, nitrophenylalkyl or nitroanilinoalkyl group in the side chain are antibacterial agents. The compounds, of which 6-(2-nitro-3,3-dimethylbutyrylamido)-penicillanic acid, 7-nitroacetamido-3-methyl-ceph-3-em-4-carboxylic acid, and 6-[D-.alpha.-(2-nitro-2-methylpropionylamido)phenylacetamido]-penicillanic acid are typical embodiments, are prepared by reacting 6-amino-penicillanic acid, 7-amino-cephalosporanic acid (or derivative thereof) or an .alpha.-substituted-.alpha. -aminoacetamido-penicillanic acid with an appropriate nitrated carboxylic acid or an equivalent nitrated acylating agent.

Growing community of inventors

Koln, Germany

Wolfgang Krohn